Naloxone Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDA
|
2011
|
|
Nanomaterial Registry
|
Resource Development
|
CDC, FDA
|
NCI, NIBIB, NIEHS
|
2010
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2008
|
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, IHS
|
NCI, NEI, NHLBI, NIA, NICHD, NIDDK, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORWH
|
1997
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD/ DPCPSI/ ODS
|
1999
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program (NKDEP)
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
1998
|
|
National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NEI, NIA, NIBIB, NICHD, NIDCD, NINDS, NINR, OD/ DPCPSI/ OBSSR
|
2009
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID, OD/ OSP
|
2004
|
|
National Science and Technology Council Committee on Science
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ OSP
|
1993
|
|
National Security Staff Combatting Antibiotic-Resistant Bacteria sub-Interagency Policy Committee (NSS CARB sub-IPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NLM, OD/ OSP
|
2014
|
|
National Toxicology Program (NTP) Executive Committee
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC, FDA
|
NCI, NIEHS
|
1985
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI National Cancer Informatics Program (NCIP) Nanotechnology Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NIBIB, NIEHS
|
2008
|
|
NCI/CCR-FDA Clinical Investigator Program
|
Research Initiative
|
FDA
|
NCI
|
2015
|
|
NCI/FDA Memorandum of Understanding for Drug Related Information
|
Resource Development
|
FDA
|
NCI
|
2012
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2007
|
|
NEI/FDA Symposium – Retina Outcome Variables
|
Meeting/ Workshop
|
FDA
|
NEI
|
2016
|
|
Newborn Screening Federal Partners Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHLBI, NICHD, NLM
|
2009
|
|
Newborn Screening Pompe Pilot Study
|
Research Initiative
|
CDC, FDA, HRSA
|
NICHD
|
2014
|
|
Newborn Screening Quality Improvement Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NICHD
|
Unknown
|
|
|